Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia

被引:0
|
作者
Ramezanali, Fariba [1 ]
Khalili, Gholamreza [2 ]
Arabipoor, Arezoo [1 ]
Lankarani, Narges Bagheri [2 ]
Moini, Ashraf [1 ]
机构
[1] ACECR, Royan Inst Reprod Biomed, Reprod Biomed Res Ctr, Dept Endocrinol & Female Infertil, POB 16635-148, Tehran, Iran
[2] ACECR, Royan Inst Reprod Biomed, Reprod Epidemiol Res Ctr, Dept Epidemiol & Reprod Hlth, Tehran, Iran
关键词
Polycystic Ovary Syndrome; Endometrial Hyperplasia; Luteinizing Hormone; Body Mass Index;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The endometrial hyperplasia measured by ultrasound in polycystic ovary syndrome (PCOS) women is strongly related to pathologic endometrial thickness, but there is no consensus on the relation between serum luteinizing hormone (LH) and either of these factors: pathologic endometrial hyperplasia and body mass index (BMI). Materials and Methods: In this observational cross-sectional study, three hundred fifty infertile PCOS women were involved in this research. An endometrial biopsy was taken by using a pipelle instrument, regardless of menstrual cycle's day and all samples were reported by the same pathologist. Basal serum LH level was compared between two subgroups (hyperplasia and non-hyperplasia). The intended population was divided into three groups according to BMI and basal serum LH, later on the comparison was made in three groups. Chi-square test was applied to compare nominal variables between groups. Mann-Whitney U, and one way ANOVA tests were used to compare means on the basis of the result of normality test. Results: The frequency of endometrial hyperplasia was 2.6%. Endometrial thickness in the patients with endometrial hyperplasia was significantly higher than that of a normal endometrium (10.78 +/- 3.70 vs. 7.90 +/- 2.86 respectively, P=0.020). There was no relation between endometrial hyperplasia and serum LH (P=0.600). The ANOVA test showed serum LH levels were not the same among three BMI groups (P=0.007). Post hoc test was also performed. It showed that the LH level in normal BMI group was significantly higher than those of other groups (P=0.005 and P=0.004), but there was no statistical difference between overweight and obese groups (P=0.8). We found no relationship between BMI and endometrial thickness in PCOS patients (P=0.6). Conclusion: Sonographic endometrial stripe thickness is predictive for endometrial hyperplasia in PCOS women. We could not find out any relationship between serum LH level and BMI with endometrial thickness in PCOS patients. However, our study confirmed a diverse relationship between serum LH level and BMI in PCOS patients.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [41] Endometrial thickness measurement throughout a menstrual cycle in non-obese infertile patients with polycystic ovary syndrome
    Ozlem Gun Eryilmaz
    Esma Sarikaya
    Cavidan Gulerman
    Serra Akar
    Nedim Cicek
    Archives of Gynecology and Obstetrics, 2012, 286 : 1597 - 1600
  • [42] Impact of body mass index on blood pressure levels in patients with polycystic ovary syndrome
    Barcellos, Cristiano R. G.
    Rocha, Michelle P.
    Hayashida, Sylvia A. Y.
    Mion Junior, Decio
    Lage, Silvia G.
    Marcondes, Jose A. M.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (07) : 1104 - 1109
  • [43] The Associations Between Serum Concentrations of Irisin and Glucose-dependent Insulinotropic Polypeptide with Body Mass Index Among Women with and Without Polycystic Ovary Syndrome
    Behboudi-Gandevani, Samira
    Hedayati, Mehdi
    Mansournia, Mohammad Ali
    Nazemipour, Maryam
    Rahmati, Maryam
    Tehrani, Fahimeh Ramezani
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 19 (04)
  • [44] The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone
    Lee, Malinda S.
    Lanes, Andrea
    Dolinko, Andrey, V
    Bailin, Alexandra
    Ginsburg, Elizabeth
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2020, 37 (09) : 2293 - 2304
  • [45] The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone
    Malinda S. Lee
    Andrea Lanes
    Andrey V. Dolinko
    Alexandra Bailin
    Elizabeth Ginsburg
    Journal of Assisted Reproduction and Genetics, 2020, 37 : 2293 - 2304
  • [46] Adjusting antimullerian hormone levels for age and body mass index improves detection of polycystic ovary syndrome
    Palomaki, Glenn E.
    Kalra, Bhanu
    Kumar, Tanya
    Patel, Amita S.
    Savjani, Gopal
    Torchen, Laura C.
    Dunaif, Andrea
    Morrison, Anthony
    Lambert-Messerlian, Geralyn M.
    Kumar, Ajay
    FERTILITY AND STERILITY, 2020, 113 (04) : 876 - +
  • [47] Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome
    Kriseman, Maya
    Mills, Charity
    Kovanci, Ertug
    Sangi-Haghpeykar, Haleh
    Gibbons, William
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2015, 32 (09) : 1313 - 1316
  • [48] Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome
    Maya Kriseman
    Charity Mills
    Ertug Kovanci
    Haleh Sangi-Haghpeykar
    William Gibbons
    Journal of Assisted Reproduction and Genetics, 2015, 32 : 1313 - 1316
  • [49] Body Mass Index stratified Anti-Mullerian hormone thresholds for diagnosing Polycystic Ovary Syndrome
    Liu, X.
    Guo, Y.
    HUMAN REPRODUCTION, 2020, 35 : 1406 - 1406
  • [50] Achilles tendon thickness and serum asprosin level significantly increases in patients with polycystic ovary syndrome
    Ozturk, Huseyin Ali
    Arici, Fatih Necip
    PEERJ, 2024, 12